Covid-19 vaccine: Serum Institute signs up for 100 million doses of vaccines for India, low and middle-income countries

Earlier, Serum Institute has collaborated with Oxford University-AstraZeneca to manufacture Covid vaccine in India and received the approval from the Drugs Controller General of India (DCGI) to conduct Phase II+III clinical trials of the COVID-19 vaccine-- COVISHIELD in India.